192 related articles for article (PubMed ID: 27698933)
21. Integrin-linked kinase, phosphorylated AKT and the prognosis of malignant pleural mesothelioma.
Watzka SB; Setinek U; Stubenberger EB; Tötsch M; Dekan G; Marcher M; Fleck T; Müller MR
Eur J Cardiothorac Surg; 2011 Feb; 39(2):180-4. PubMed ID: 20580243
[TBL] [Abstract][Full Text] [Related]
22. ERCC1, PARP-1, and AQP1 as predictive biomarkers in colon cancer patients receiving adjuvant chemotherapy.
Abdelrahman AE; Ibrahim DA; El-Azony A; Alnagar AA; Ibrahim A
Cancer Biomark; 2020; 27(2):251-264. PubMed ID: 31903985
[TBL] [Abstract][Full Text] [Related]
23. Identification of a Five-Gene Signature for Predicting Survival in Malignant Pleural Mesothelioma Patients.
Bai Y; Wang X; Hou J; Geng L; Liang X; Ruan Z; Guo H; Nan K; Jiang L
Front Genet; 2020; 11():899. PubMed ID: 32849853
[TBL] [Abstract][Full Text] [Related]
24. Global gene expression profiling of pleural mesotheliomas: overexpression of aurora kinases and P16/CDKN2A deletion as prognostic factors and critical evaluation of microarray-based prognostic prediction.
López-Ríos F; Chuai S; Flores R; Shimizu S; Ohno T; Wakahara K; Illei PB; Hussain S; Krug L; Zakowski MF; Rusch V; Olshen AB; Ladanyi M
Cancer Res; 2006 Mar; 66(6):2970-9. PubMed ID: 16540645
[TBL] [Abstract][Full Text] [Related]
25. XRCC1 and ERCC1 variants modify malignant mesothelioma risk: a case-control study.
Betti M; Ferrante D; Padoan M; Guarrera S; Giordano M; Aspesi A; Mirabelli D; Casadio C; Ardissone F; Ruffini E; Betta PG; Libener R; Guaschino R; Matullo G; Piccolini E; Magnani C; Dianzani I
Mutat Res; 2011 Mar; 708(1-2):11-20. PubMed ID: 21277872
[TBL] [Abstract][Full Text] [Related]
26. The prognostic value of excision repair cross-complementation group 1 (ERCC1) in patients with small cell lung cancer (SCLC) receiving platinum-based chemotherapy: evidence from meta-analysis.
Yang Y; Luo X; Yang N; Feng R; Xian L
PLoS One; 2014; 9(11):e111651. PubMed ID: 25375151
[TBL] [Abstract][Full Text] [Related]
27. Expression of DNA repair genes in ovarian cancer samples: biological and clinical considerations.
Ganzinelli M; Mariani P; Cattaneo D; Fossati R; Fruscio R; Corso S; Ricci F; Broggini M; Damia G
Eur J Cancer; 2011 May; 47(7):1086-94. PubMed ID: 21216588
[TBL] [Abstract][Full Text] [Related]
28. Response to chemotherapy is predictive in relation to longer overall survival in an individual patient combined-analysis with pleural mesothelioma.
Blayney JK; Ceresoli GL; Castagneto B; O'Brien ME; Hasan B; Sylvester R; Rudd R; Steele J; Busacca S; Porta C; Mutti L; O'Byrne KJ; Scullin P; Gaafar R; Baas P; Van Meerbeeck J; Fennell DA
Eur J Cancer; 2012 Nov; 48(16):2983-92. PubMed ID: 22704893
[TBL] [Abstract][Full Text] [Related]
29. Differential p16/INK4A cyclin-dependent kinase inhibitor expression correlates with chemotherapy efficacy in a cohort of 88 malignant pleural mesothelioma patients.
Jennings CJ; Murer B; O'Grady A; Hearn LM; Harvey BJ; Kay EW; Thomas W
Br J Cancer; 2015 Jun; 113(1):69-75. PubMed ID: 26057448
[TBL] [Abstract][Full Text] [Related]
30. Induction of senescence markers after neo-adjuvant chemotherapy of malignant pleural mesothelioma and association with clinical outcome: an exploratory analysis.
Sidi R; Pasello G; Opitz I; Soltermann A; Tutic M; Rehrauer H; Weder W; Stahel RA; Felley-Bosco E
Eur J Cancer; 2011 Jan; 47(2):326-32. PubMed ID: 21036600
[TBL] [Abstract][Full Text] [Related]
31. Expression of ERCC1, MSH2 and PARP1 in non-small cell lung cancer and prognostic value in patients treated with platinum-based chemotherapy.
Xie KJ; He HE; Sun AJ; Liu XB; Sun LP; Dong XJ
Asian Pac J Cancer Prev; 2014; 15(6):2591-6. PubMed ID: 24761869
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of p16/cdkn2a loss in pleural malignant mesotheliomas.
Dacic S; Kothmaier H; Land S; Shuai Y; Halbwedl I; Morbini P; Murer B; Comin C; Galateau-Salle F; Demirag F; Zeren H; Attanoos R; Gibbs A; Cagle P; Popper H
Virchows Arch; 2008 Dec; 453(6):627-35. PubMed ID: 18958493
[TBL] [Abstract][Full Text] [Related]
33. The DNA repair proteins BRCA1 and ERCC1 as predictive markers in sporadic ovarian cancer.
Weberpals J; Garbuio K; O'Brien A; Clark-Knowles K; Doucette S; Antoniouk O; Goss G; Dimitroulakos J
Int J Cancer; 2009 Feb; 124(4):806-15. PubMed ID: 19035454
[TBL] [Abstract][Full Text] [Related]
34. Patterns of failure following surgical resection for malignant pleural mesothelioma.
Jänne PA; Baldini EH
Thorac Surg Clin; 2004 Nov; 14(4):567-73. PubMed ID: 15559064
[TBL] [Abstract][Full Text] [Related]
35. Validation of EORTC and CALGB prognostic models in surgical patients submitted to diagnostic, palliative or curative surgery for malignant pleural mesothelioma.
Sandri A; Guerrera F; Roffinella M; Olivetti S; Costardi L; Oliaro A; Filosso PL; Lausi PO; Ruffini E
J Thorac Dis; 2016 Aug; 8(8):2121-7. PubMed ID: 27621868
[TBL] [Abstract][Full Text] [Related]
36. Transcriptomic Analysis of the Claudin Interactome in Malignant Pleural Mesothelioma: Evaluation of the Effect of Disease Phenotype, Asbestos Exposure, and CDKN2A Deletion Status.
Rouka E; Vavougios GD; Solenov EI; Gourgoulianis KI; Hatzoglou C; Zarogiannis SG
Front Physiol; 2017; 8():156. PubMed ID: 28377727
[TBL] [Abstract][Full Text] [Related]
37. An overview of neoadjuvant chemotherapy in the multimodality treatment of malignant pleural mesothelioma.
Pasello G; Ceresoli GL; Favaretto A
Cancer Treat Rev; 2013 Feb; 39(1):10-7. PubMed ID: 22459200
[TBL] [Abstract][Full Text] [Related]
38. Quantitative analyses at baseline and interim PET evaluation for response assessment and outcome definition in patients with malignant pleural mesothelioma.
Lopci E; Zucali PA; Ceresoli GL; Perrino M; Giordano L; Gianoncelli L; Lorenzi E; Gemelli M; Santoro A; Chiti A
Eur J Nucl Med Mol Imaging; 2015 Apr; 42(5):667-75. PubMed ID: 25403555
[TBL] [Abstract][Full Text] [Related]
39. A New Prognostic Score Supporting Treatment Allocation for Multimodality Therapy for Malignant Pleural Mesothelioma: A Review of 12 Years' Experience.
Opitz I; Friess M; Kestenholz P; Schneiter D; Frauenfelder T; Nguyen-Kim TD; Seifert B; Hoda MA; Klepetko W; Stahel RA; Weder W
J Thorac Oncol; 2015 Nov; 10(11):1634-41. PubMed ID: 26317916
[TBL] [Abstract][Full Text] [Related]
40. Malignant pleural mesothelioma.
Chen SE; Pace MB
Am J Health Syst Pharm; 2012 Mar; 69(5):377-85. PubMed ID: 22345416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
